A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Advanced Gastric Cancer.
NCT05188209
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced or Metastatic Gastric Cancer
Advanced or Metastatic Gastroesophageal Junction Carcinoma
Interventions
DRUG:
MRG003
Sponsor
Shanghai Miracogen Inc.